Global vaccine coalition unveils ambitious plan to immunize 300 million children
Gavi, the Vaccine Alliance, has unveiled an ambitious plan to expand the number of doses…
Author: STAT
Hormone therapy during menopause raises breast cancer risk for years, study finds
A sweeping new analysis adds to the evidence that many women who take hormone therapy…
Listen: Purdue, J&J, and a week of big opioid crisis news
What does Dr. Richard Sackler sound like? When is $500 million a small amount of…
Opinion: Medical education needs to stop burning out students — now
Students’ time in medical school should help them grow and become insightful, caring doctors. Instead,…
Opinion: Are reasonable restraints on drug price increases doomed by pharma lobbying?
In a rare but important display of congressional bipartisanship, Sens. Chuck Grassley (R-Iowa) and Ron…
With new grants, Gates Foundation takes an early step toward a universal flu vaccine
Scientific teams from inside and outside the world of influenza research have been awarded funding…
STAT Plus: Can less be more? A heretical approach to chemotherapy is extending cancer patients’ lives
No scientist with even a rudimentary moral compass and an ounce of intellectual humility takes…
STAT Plus: Medicare Part D paid millions for drugs already covered by Part A hospice benefits
Despite a previous warning, the Center for Medicare and Medicaid Services failed to take steps…
STAT Plus: Dutch health minister threatens to name and shame pharma over prices
In an unusual move, the Netherlands health minister wrote an open letter to the pharmaceutical…
Vertex sinks on reports of deaths of patients taking cystic fibrosis drug
Thirty patients have died after taking a Vertex Pharmaceuticals treatment for cystic fibrosis, according to…
STAT Plus: The J&J opioid case in Oklahoma darkens the outlook for other drug companies
Now that an Oklahoma state court judge has ruled Johnson & Johnson (JNJ) must pay…
STAT Plus: Battleground narrowed in CRISPR patent case between University of California and Broad
The contours of the latest battle over patents on the CRISPR genome editing technology are…
STAT Plus: Pharmalittle: J&J ordered to pay $572m in Oklahoma opioid case; Canada reassures pharma on importation
Rise and shine, everyone, another busy day is on the way. Yes, this may be…
Watch: In never-before-seen video, Purdue’s Richard Sackler defends OxyContin marketing
This story is a collaboration between STAT, ProPublica, and ABC News. Members of the intensely…
STAT Plus: Canadian officials say ‘all options’ on the table in responding to Trump importation plan
A version of this story also appeared in D.C. Diagnosis, STAT’s weekly newsletter about the…
Opinion: Transplanting islet cells can fix brittle diabetes. Why isn’t it available in the U.S.?
The term “type 1 diabetes” generally conjures up images of insulin. That makes sense, because…
.jpg)
Suicide is a leading cause of death in the U.S. Here’s how Warren, Sanders, and other candidates want to help change that
To bring down the rising suicide rate in the U.S., Cory Booker wants to appoint…
STAT Plus: An FDA report reveals the agency believed Novartis data problems were resolved months ago
Shortly before serious data problems surfaced in mid-March at a troubled Novartis (NVS) unit, a…
Oklahoma judge finds Johnson & Johnson fueled opioid crisis
NORMAN, Okla. — An Oklahoma judge on Monday found Johnson & Johnson and its subsidiaries…
Opinion: Lost lives and long odds: Inside STAT’s decision to take on Purdue
Last month, I got an email from a dear old friend from Kentucky with devastating…
STAT wins long legal fight as Kentucky Supreme Court clears way for release of Purdue OxyContin files
FRANKFORT, Ky. — After a 3 1/2 year legal battle, secret records about Purdue Pharma’s…
STAT Plus: Pharmalittle: Merck calls new Canadian pricing rules unconstitutional; J&J ruling today
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT Plus: U.K. lawmaker renews push to sanction companies and universities for clinical trial transparency failures
Amid a push to encourage companies and universities to register and report clinical trials in…
Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger
Amgen said Monday that it will buy the psoriasis pill Otezla from Celgene, which is…
Opinion: Stop treating medical residents like indentured servants
Hundreds of years ago, poor immigrants were forced to become indentured servants to repay the…
Federal rules threaten to discourage undocumented immigrants from vaccinating children
Pediatricians and public health officials are worried vaccination rates among children of immigrants will fall…
STAT Plus: Pharmalittle: Trump pushes VA to buy controversial J&J drug; Gilead challenges U.S. patents on HIV pill
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
Opinion: Gene editing to stop Lyme disease: caution is warranted
When I first learned about Mice Against Ticks, I was shocked but also intrigued —…
Opinion: A community-guided genome editing project can fight Lyme disease
The epidemic of Lyme disease is an ecological problem of our own making: We have…
STAT Plus: AI startups are racing into drug development. Here’s 5 burning questions about which will survive
SAN FRANCISCO — About two years ago, Simon Smith started counting the startups trying to…
Can a new Lyme disease vaccine overcome a history of distrust and failure?
As the threat of Lyme disease grows and fears surrounding it spread faster than the…
STAT Plus: Gilead challenges U.S. government patents on a controversial HIV prevention pill
In an unexpected move, Gilead Sciences is challenging patents held by the federal government for…
Scientists routinely cure brain disorders in mice but not us. A new study helps explain why
Lab mice endure a lot for science, but there’s often one (temporary) compensation: near-miraculous recovery…
STAT Plus: The cost of diabetes drugs is causing more Americans to skip their meds
In response to the rising cost of medicines, a growing number of people with diabetes…
STAT Plus: Pharmalittle: AstraZeneca stumbles in lung cancer; FDA official on Novartis data scandal says ‘we got lucky’
Rise and shine, everyone, the middle of the week is already here. Time flies when…
NIH will soon share genetic data with those who participated in precision medicine study
WASHINGTON — The nearly 200,000 Americans who have trusted federal scientists with their DNA, their…
Opinion: Trump is trying to end secret health care price negotiations. You should be on his side
President Trump signed an executive order in June that could force price disclosure in health…
STAT Plus: Warning of an AI winter, a skeptic argues deep learning in medicine needs a reboot
In his writings, Gary Marcus is clear about two things: Artificial intelligence is an extremely…
FDA on Novartis data manipulation controversy: ‘We happened to be lucky’
Since the Food and Drug Administration blasted Novartis earlier this month over data manipulation, one…
STAT Plus: Drug maker pays $200,000 to settle charges of unfairly disclosing material info to analysts
Talk about playing favorites. A small drug company called TherapeuticsMD (TXMD) agreed to pay $200,000…
Endo agrees to pay $10 million to settle landmark opioid case brought by Ohio counties
As a landmark trial over the opioid crisis grows closer, Endo International (ENDP) agreed to…
STAT Plus: Pharmalittle: Two drug makers may settle opioid case; FDA hands Sarepta a surprising setback
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT Plus: FDA’s Sarepta rejection is rooted in the past, and will weigh on its future
The Food and Drug Administration’s surprise decision to reject the company’s Duchenne drug Vyondys 53…
STAT Plus: A drug maker replaces an old treatment and boosts the price by 1,300%
The Trump administration may brag that drug makers are dialing back price hikes, but a…
Opinion: FDA should use its existing program to qualify new tools for drug safety testing
The field of toxicology — determining whether a product is safe or harmful — is…
‘Maisie’s Army’: How a grassroots group is mobilizing to help toddlers access a lifesaving drug
When the family of 20-month-old Maisie Green heard late last month that their insurance company…
Top scientist categorically denies any wrongdoing in Novartis data manipulation scandal
The Novartis scientist who was ousted by the drug maker in connection with a scandal…
Sarepta stumbles on FDA rejection of a new drug to treat Duchenne muscular dystrophy
Sarepta Therapeutics was dealt a surprising setback Monday when the Food and Drug Administration rejected…
STAT Plus: AIDS activists say Gilead put profits over patients — and misled Congress about an HIV pill
Last May, Gilead Sciences (GILD) chief executive Daniel O’Day testified before Congress that a revised…
STAT Plus: Despite their pledges, Democrats haven’t yet lowered drug prices. Here’s how they’re explaining themselves
TAMWORTH, N.H. — Rep. Chris Pappas strode into the Tri-County Cap, a nondescript office building…